Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study

Suspended

Phase N/A Results N/A

Summary of Purpose

Prospective, single-arm, open label, Safety and Performance clinical investigation. Trial Stopped: Amnis supplier of wire coating is ceasing sale of this raw material due to relocation of their sub contractor's facilities. Amnis must replace the wire.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 January 2018.

8 Jan 2017 5 Dec 2016 1 Oct 2019 1 Oct 2019 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts